The hierarchy of the global cancer therapeutics sector is being redefined in 2026 by a select group of visionary companies. According to the latest Oncology Drugs Market Key Manufacturers report, the competitive landscape is no longer dominated solely by traditional chemotherapy producers, but by "biotech-first" giants who have mastered the art of molecular targeting. Companies like...